 | Morgan Stanley Raises Neurocrine Biosciences (NASDAQ:NBIX) Price Target to $121.00
www.americanbankingnews.com - January 17 at 10:53 AM |
| Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Forecasted to Earn FY2020 Earnings of $3.87 Per Share
www.americanbankingnews.com - January 15 at 6:46 AM |
| Short Interest in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Declines By 8.4%
www.americanbankingnews.com - January 14 at 4:34 PM |
 | Neurocrine Biosciences (NBIX) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow
seekingalpha.com - January 14 at 4:05 PM |
| Oppenheimer Analysts Raise Earnings Estimates for Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
www.americanbankingnews.com - January 14 at 6:02 AM |
| Neurocrine Biosciences (NASDAQ:NBIX) Given New $132.00 Price Target at Oppenheimer
www.americanbankingnews.com - January 13 at 11:08 AM |
| Neurocrine Bio expects $238M in Q4 Ingrezza sales
seekingalpha.com - January 12 at 8:35 PM |
 | Neurocrine Biosciences Provides Preliminary Fourth Quarter and Full-Year 2019 Net Product Sales Results and 2020 Program Milestones
finance.yahoo.com - January 12 at 8:35 PM |
| Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Insider Eiry Roberts Sells 2,632 Shares
www.americanbankingnews.com - January 10 at 6:46 PM |
| AMRX vs. NBIX: Which Stock Is the Better Value Option?
finance.yahoo.com - January 10 at 3:17 PM |
 | Idorsia Pharmaceuticals Ltd: Neurocrine Biosciences and Idorsia amend option agreement to license novel treatment for rare pediatric epilepsy
www.finanznachrichten.de - January 10 at 2:38 AM |
 | Neurocrine Biosciences and Idorsia Amend Option Agreement to License Novel Treatment for Rare Pediatric Epilepsy
www.prnewswire.com - January 10 at 1:57 AM |
| Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Receives Average Recommendation of "Buy" from Analysts
www.americanbankingnews.com - January 10 at 1:50 AM |
| Will Neurocrine (NBIX) Beat Estimates Again in Its Next Earnings Report?
finance.yahoo.com - January 9 at 4:36 PM |
 | Why Neurocrine Biosciences Soared 50.5% in 2019
www.fool.com - January 7 at 10:12 PM |
| Neurocrine Biosciences to Present at the 38th Annual J.P. Morgan Healthcare Conference Live Audio Webcast will be on January 13, 2020
finance.yahoo.com - January 6 at 7:28 PM |
| Is Neurocrine Biosciences, Inc.'s (NASDAQ:NBIX) CEO Pay Fair?
finance.yahoo.com - January 6 at 2:28 PM |
| Brokerages Expect Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Will Announce Quarterly Sales of $220.48 Million
www.americanbankingnews.com - January 4 at 5:32 AM |
| Analysts Anticipate Neurocrine Biosciences, Inc. (NASDAQ:NBIX) to Post $0.73 Earnings Per Share
www.americanbankingnews.com - January 2 at 6:22 AM |
| How Did Neurocrine Biosciences, Inc. (NBIX) Compare Against Top Hedge Fund Stocks in 2019?
finance.yahoo.com - December 25 at 6:03 PM |
| S&P Rises for Fourth Straight Week
finance.yahoo.com - December 23 at 12:24 PM |
 | Commit To Purchase Neurocrine Biosciences At $85, Earn 4.9% Using Options
www.nasdaq.com - December 12 at 1:01 PM |
| Aurelius bearish on Neurocrine Biosciences
seekingalpha.com - December 11 at 2:26 PM |
| With EPS Growth And More, Neurocrine Biosciences (NASDAQ:NBIX) Is Interesting
finance.yahoo.com - December 6 at 1:43 PM |
| Hedge Funds Have Never Been This Bullish On Neurocrine Biosciences, Inc. (NBIX)
finance.yahoo.com - November 27 at 7:59 AM |
 | Neurocrine Biosciences to Present at Evercore ISI 2nd Annual HealthCONx Conference
www.marketwatch.com - November 26 at 4:19 PM |
| Neurocrine Biosciences Publishes Long-Term INGREZZA® (valbenazine) Data in the Journal of Clinical Psychopharmacology Demonstrating Once-Daily 40 mg and 80 mg Capsules Reduced Involuntary Movements in Adults with Tardive Dyskinesia
finance.yahoo.com - November 12 at 6:27 PM |
| Edited Transcript of NBIX earnings conference call or presentation 4-Nov-19 9:30pm GMT
finance.yahoo.com - November 8 at 10:13 PM |
 | BRIEF-Neurocrine Biosciences Announces Third Quarter Results
www.msn.com - November 5 at 7:51 PM |
| Neurocrine Biosciences, Inc. (NBIX) CEO Kevin Gorman on Q3 2019 Results - Earnings Call Transcript
seekingalpha.com - November 5 at 3:16 AM |
| Neurocrine Biosciences Inc (NBIX) Q3 2019 Earnings Call Transcript
www.nasdaq.com - November 4 at 11:45 PM |
| Neurocrine Biosciences (NBIX) Beats Q3 Earnings and Revenue Estimates
finance.yahoo.com - November 4 at 11:45 PM |
| Neurocrine Biosciences Inc Reveals Rise In Q3 Earnings
www.nasdaq.com - November 4 at 6:44 PM |
| Neurocrine Biosciences EPS misses by $0.09, beats on revenue
seekingalpha.com - November 4 at 6:44 PM |
| Is Neurocrine Biosciences (NASDAQ:NBIX) A Risky Investment?
finance.yahoo.com - November 4 at 6:44 PM |
| Neurocrine Biosciences Reports Third Quarter 2019 Financial Results
finance.yahoo.com - November 4 at 6:44 PM |
| Neurocrine Biosciences, Inc. Common Stock (NBIX) Earnings Report Date
www.nasdaq.com - November 3 at 11:21 PM |
| Neurocrine Biosciences Q3 2019 Earnings Preview
seekingalpha.com - November 3 at 11:21 PM |
| Why Earnings Season Could Be Great for Neurocrine Biosciences (NBIX)
finance.yahoo.com - November 1 at 1:32 PM |
| Neurocrine Biosciences (NBIX) Reports Next Week: Wall Street Expects Earnings Growth
finance.yahoo.com - October 28 at 12:31 PM |
| Were Hedge Funds Right About Piling Into Neurocrine Biosciences (NBIX)?
finance.yahoo.com - October 22 at 7:07 PM |
| Bet on Top-Notch Sector ETFs & Stocks to Sparkle Q4
finance.yahoo.com - October 15 at 1:23 PM |
| Neurocrine Biosciences Announces Conference Call and Webcast of Third Quarter 2019 Financial Results
www.marketwatch.com - October 14 at 5:58 PM |
| Zoetis (ZTS) Soars to 52-Week High, Time to Cash Out?
finance.yahoo.com - October 14 at 12:57 PM |
 | Neurocrine Biosciences Presents New Data Analyses...
www.benzinga.com - October 4 at 10:22 PM |
| Neurocrine Biosciences Presents New Data Analyses Demonstrating Long-Term Effects of INGREZZA® (valbenazine) 40 mg Once-Daily in Patients with Tardive Dyskinesia at the 2019 Annual Psych Congress
www.prnewswire.com - October 4 at 7:55 PM |
| Neurocrine Biosciences to Present Data Analyses Demonstrating the Long-Term Effectiveness of INGREZZA® (valbenazine) in Patients with Tardive Dyskinesia at the 2019 Annual Psych Congress
finance.yahoo.com - October 1 at 4:31 PM |
| Neurocrine Biosciences Appoints David W. Boyer as Chief Corporate Affairs Officer
finance.yahoo.com - September 30 at 8:11 PM |
| Investors Who Bought Neurocrine Biosciences (NASDAQ:NBIX) Shares Five Years Ago Are Now Up 476%
finance.yahoo.com - September 27 at 5:33 PM |
| Neurocrine Biosciences to Present Data on INGREZZA® (valbenazine) for Tardive Dyskinesia; Opicapone and VY-AADC for Parkinson's Disease, at the 2019 International Congress of Parkinson's Disease and Movement Disorders®
finance.yahoo.com - September 17 at 8:05 PM |
